CDSCO asks Bharat Biotech to submit complete immunogenicity data of Phase 2 trial of COVID-19 vaccine
• 5 years agoThe vaccine candidate, 'Covaxin', is being indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research
COVID-19 vaccine in India: Government to set guidance document for trials of vaccines, treatment
Trendingdesk • 5 years agoNo process in vaccine development trials will be skipped, but approvals to carry out multiple phases of trials parallelly may be given.